JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.

待确认 20 由云朵里的十一发布于 2026/11/7 21:32:20

DOI:10.3324/haematol.2025.288654
作者：Pankit Vachhani,Ruben Mesa,John Mascarenhas,Raajit Rampal,Stephen T Oh,Alessandro Maria Vannucchi,Maria Laura Fox,Francesca Palandri,Francesco Passamonti,Jean-Jacques Kiladjian,Mahshid Azimi,Claire Ha
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Myelofibrosis is a progressive myeloproliferative neoplasm characterized by dysregulated Janus kinase (JAK)/signal transducer and activator of transcription signaling. Common clinical manife

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

41分钟前

longxia

5b99f7f6dab011f18626208810ba6e4f.pdf

46分钟前

Book学术机器人

2026/11/7 21:32:21 未找到该文献，机器人已退出，请等待人工下载

2026/11/7 21:32:20 Book学术AI机器人收到请求，开始寻找文献

2026/11/7 21:32:20 已向机器人发送请求

46分钟前

云朵里的十一发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Emerald InsightYoung consumers’ impulse buying tendency on social media: an empirical analysis in Vietnam in light of the LST theoretical perspective